About This Study
The purpose of this study is to learn more about a new treatment for people with bladder cancer that has not spread into the muscle but could become more serious over time. This is called high-risk, non-muscle invasive bladder cancer (NMIBC). Our researchers want to see if a treatment called cretostimogene grenadenorepvec can safely kill cancer cells, stop the tumor from coming back, and for how long it can help.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100+ years old
- Female
- Male
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Charlotte, NC